Condition | Indicated | Relationship Strength | Studies | Trials |
Peripheral Arterial Diseases [description not available] | 0 | 3.7 | 5 | 0 |
Diabetes Mellitus, Adult-Onset [description not available] | 0 | 7 | 6 | 2 |
Disease Models, Animal Naturally-occurring or experimentally-induced animal diseases with pathological processes analogous to human diseases. | 0 | 5 | 7 | 1 |
Diabetes Mellitus, Type 2 A subclass of DIABETES MELLITUS that is not INSULIN-responsive or dependent (NIDDM). It is characterized initially by INSULIN RESISTANCE and HYPERINSULINEMIA; and eventually by GLUCOSE INTOLERANCE; HYPERGLYCEMIA; and overt diabetes. Type II diabetes mellitus is no longer considered a disease exclusively found in adults. Patients seldom develop KETOSIS but often exhibit OBESITY. | 0 | 7 | 6 | 2 |
Ischemia A hypoperfusion of the BLOOD through an organ or tissue caused by a PATHOLOGIC CONSTRICTION or obstruction of its BLOOD VESSELS, or an absence of BLOOD CIRCULATION. | 0 | 3.52 | 4 | 0 |
Peripheral Arterial Disease Lack of perfusion in the EXTREMITIES resulting from atherosclerosis. It is characterized by INTERMITTENT CLAUDICATION, and an ANKLE BRACHIAL INDEX of 0.9 or less. | 0 | 3.7 | 5 | 0 |
Kidney Failure A severe irreversible decline in the ability of kidneys to remove wastes, concentrate URINE, and maintain ELECTROLYTE BALANCE; BLOOD PRESSURE; and CALCIUM metabolism. | 0 | 2.25 | 1 | 0 |
Cirrhosis [description not available] | 0 | 2.61 | 2 | 0 |
Innate Inflammatory Response [description not available] | 0 | 2.25 | 1 | 0 |
Fibrosis Any pathological condition where fibrous connective tissue invades any organ, usually as a consequence of inflammation or other injury. | 0 | 7.61 | 2 | 0 |
Inflammation A pathological process characterized by injury or destruction of tissues caused by a variety of cytologic and chemical reactions. It is usually manifested by typical signs of pain, heat, redness, swelling, and loss of function. | 0 | 7.25 | 1 | 0 |
Renal Insufficiency Conditions in which the KIDNEYS perform below the normal level in the ability to remove wastes, concentrate URINE, and maintain ELECTROLYTE BALANCE; BLOOD PRESSURE; and CALCIUM metabolism. Renal insufficiency can be classified by the degree of kidney damage (as measured by the level of PROTEINURIA) and reduction in GLOMERULAR FILTRATION RATE. | 0 | 2.25 | 1 | 0 |
Diabetic Glomerulosclerosis [description not available] | 0 | 6.28 | 3 | 2 |
Blood Pressure, High [description not available] | 0 | 4.55 | 1 | 1 |
Diabetic Nephropathies KIDNEY injuries associated with diabetes mellitus and affecting KIDNEY GLOMERULUS; ARTERIOLES; KIDNEY TUBULES; and the interstitium. Clinical signs include persistent PROTEINURIA, from microalbuminuria progressing to ALBUMINURIA of greater than 300 mg/24 h, leading to reduced GLOMERULAR FILTRATION RATE and END-STAGE RENAL DISEASE. | 0 | 6.28 | 3 | 2 |
Hypertension Persistently high systemic arterial BLOOD PRESSURE. Based on multiple readings (BLOOD PRESSURE DETERMINATION), hypertension is currently defined as when SYSTOLIC PRESSURE is consistently greater than 140 mm Hg or when DIASTOLIC PRESSURE is consistently 90 mm Hg or more. | 0 | 9.55 | 1 | 1 |
Cardiac Failure [description not available] | 0 | 5.99 | 2 | 2 |
Heart Failure A heterogeneous condition in which the heart is unable to pump out sufficient blood to meet the metabolic need of the body. Heart failure can be caused by structural defects, functional abnormalities (VENTRICULAR DYSFUNCTION), or a sudden overload beyond its capacity. Chronic heart failure is more common than acute heart failure which results from sudden insult to cardiac function, such as MYOCARDIAL INFARCTION. | 1 | 7.99 | 2 | 2 |
Gastric Outlet Obstruction The hindering of output from the STOMACH into the SMALL INTESTINE. This obstruction may be of mechanical or functional origin such as EDEMA from PEPTIC ULCER; NEOPLASMS; FOREIGN BODIES; or AGING. | 0 | 3.42 | 1 | 1 |
Cardiometabolic Syndrome A cluster of symptoms that are risk factors for CARDIOVASCULAR DISEASES and TYPE 2 DIABETES MELLITUS. The major components not only include metabolic dysfunctions of METABOLIC SYNDROME but also HYPERTENSION, and ABDOMINAL OBESITY. | 0 | 3.42 | 1 | 1 |
Fatty Liver, Nonalcoholic [description not available] | 0 | 3.87 | 2 | 1 |
Breast Cancer [description not available] | 0 | 5.51 | 4 | 4 |
Cancer of Colon [description not available] | 0 | 3.42 | 1 | 1 |
Glial Cell Tumors [description not available] | 0 | 3.42 | 1 | 1 |
Cancer of Liver [description not available] | 0 | 3.42 | 1 | 1 |
Infections, Plasmodium [description not available] | 0 | 3.42 | 1 | 1 |
Cells, Neoplasm Circulating [description not available] | 0 | 3.42 | 1 | 1 |
Benign Neoplasms [description not available] | 0 | 3.42 | 1 | 1 |
Morbid Obesity [description not available] | 0 | 5.51 | 4 | 4 |
Cancer of Pancreas [description not available] | 0 | 3.42 | 1 | 1 |
Complication, Postoperative [description not available] | 0 | 5.51 | 4 | 4 |
Cancer of Prostate [description not available] | 0 | 5.51 | 4 | 4 |
Cancer of Stomach [description not available] | 0 | 5.51 | 4 | 4 |
Leanness [description not available] | 0 | 3.42 | 1 | 1 |
Thrombopenia [description not available] | 0 | 3.42 | 1 | 1 |
Cancer of the Urinary Tract [description not available] | 0 | 3.42 | 1 | 1 |
Infections, Helicobacter [description not available] | 0 | 3.42 | 1 | 1 |
Anemia, Splenic [description not available] | 0 | 3.42 | 1 | 1 |
Infection, Postoperative Wound [description not available] | 0 | 3.42 | 1 | 1 |
Local Neoplasm Recurrence [description not available] | 0 | 5.51 | 4 | 4 |
Invasiveness, Neoplasm [description not available] | 0 | 3.42 | 1 | 1 |
Breast Neoplasms Tumors or cancer of the human BREAST. | 0 | 5.51 | 4 | 4 |
Carcinoma, Transitional Cell A malignant neoplasm derived from TRANSITIONAL EPITHELIAL CELLS, occurring chiefly in the URINARY BLADDER; URETERS; or RENAL PELVIS. | 0 | 3.42 | 1 | 1 |
Colonic Neoplasms Tumors or cancer of the COLON. | 0 | 3.42 | 1 | 1 |
Glioma Benign and malignant central nervous system neoplasms derived from glial cells (i.e., astrocytes, oligodendrocytes, and ependymocytes). Astrocytes may give rise to astrocytomas (ASTROCYTOMA) or glioblastoma multiforme (see GLIOBLASTOMA). Oligodendrocytes give rise to oligodendrogliomas (OLIGODENDROGLIOMA) and ependymocytes may undergo transformation to become EPENDYMOMA; CHOROID PLEXUS NEOPLASMS; or colloid cysts of the third ventricle. (From Escourolle et al., Manual of Basic Neuropathology, 2nd ed, p21) | 0 | 3.42 | 1 | 1 |
Liver Neoplasms Tumors or cancer of the LIVER. | 0 | 3.42 | 1 | 1 |
Malaria A protozoan disease caused in humans by four species of the PLASMODIUM genus: PLASMODIUM FALCIPARUM; PLASMODIUM VIVAX; PLASMODIUM OVALE; and PLASMODIUM MALARIAE; and transmitted by the bite of an infected female mosquito of the genus ANOPHELES. Malaria is endemic in parts of Asia, Africa, Central and South America, Oceania, and certain Caribbean islands. It is characterized by extreme exhaustion associated with paroxysms of high FEVER; SWEATING; shaking CHILLS; and ANEMIA. Malaria in ANIMALS is caused by other species of plasmodia. | 0 | 3.42 | 1 | 1 |
Neoplasms New abnormal growth of tissue. Malignant neoplasms show a greater degree of anaplasia and have the properties of invasion and metastasis, compared to benign neoplasms. | 0 | 3.42 | 1 | 1 |
Obesity A status with BODY WEIGHT that is grossly above the recommended standards, usually due to accumulation of excess FATS in the body. The standards may vary with age, sex, genetic or cultural background. In the BODY MASS INDEX, a BMI greater than 30.0 kg/m2 is considered obese, and a BMI greater than 40.0 kg/m2 is considered morbidly obese (MORBID OBESITY). | 0 | 3.42 | 1 | 1 |
Obesity, Morbid The condition of weighing two, three, or more times the ideal weight, so called because it is associated with many serious and life-threatening disorders. In the BODY MASS INDEX, morbid obesity is defined as having a BMI greater than 40.0 kg/m2. | 0 | 5.51 | 4 | 4 |
Pancreatic Neoplasms Tumors or cancer of the PANCREAS. Depending on the types of ISLET CELLS present in the tumors, various hormones can be secreted: GLUCAGON from PANCREATIC ALPHA CELLS; INSULIN from PANCREATIC BETA CELLS; and SOMATOSTATIN from the SOMATOSTATIN-SECRETING CELLS. Most are malignant except the insulin-producing tumors (INSULINOMA). | 0 | 3.42 | 1 | 1 |
Postoperative Complications Pathologic processes that affect patients after a surgical procedure. They may or may not be related to the disease for which the surgery was done, and they may or may not be direct results of the surgery. | 0 | 5.51 | 4 | 4 |
Pregnancy The status during which female mammals carry their developing young (EMBRYOS or FETUSES) in utero before birth, beginning from FERTILIZATION to BIRTH. | 0 | 3.42 | 1 | 1 |
Prostatic Neoplasms Tumors or cancer of the PROSTATE. | 0 | 5.51 | 4 | 4 |
Stomach Neoplasms Tumors or cancer of the STOMACH. | 0 | 5.51 | 4 | 4 |
Thrombocytopenia A subnormal level of BLOOD PLATELETS. | 0 | 3.42 | 1 | 1 |
Helicobacter Infections Infections with organisms of the genus HELICOBACTER, particularly, in humans, HELICOBACTER PYLORI. The clinical manifestations are focused in the stomach, usually the gastric mucosa and antrum, and the upper duodenum. This infection plays a major role in the pathogenesis of type B gastritis and peptic ulcer disease. | 0 | 3.42 | 1 | 1 |
Metabolic Syndrome A cluster of symptoms that are risk factors for CARDIOVASCULAR DISEASES and TYPE 2 DIABETES MELLITUS. The major components of metabolic syndrome include ABDOMINAL OBESITY; atherogenic DYSLIPIDEMIA; HYPERTENSION; HYPERGLYCEMIA; INSULIN RESISTANCE; a proinflammatory state; and a prothrombotic (THROMBOSIS) state. | 0 | 3.42 | 1 | 1 |
Non-alcoholic Fatty Liver Disease Fatty liver finding without excessive ALCOHOL CONSUMPTION. | 0 | 3.87 | 2 | 1 |
Disease Exacerbation [description not available] | 0 | 2.25 | 1 | 0 |
Nephritis Inflammation of any part of the KIDNEY. | 0 | 2.25 | 1 | 0 |
Colonic Inertia Symptom characterized by the passage of stool once a week or less. | 0 | 4.55 | 1 | 1 |
Dizzyness [description not available] | 0 | 4.55 | 1 | 1 |
Drop Attack [description not available] | 0 | 4.55 | 1 | 1 |
Albuminuria The presence of albumin in the urine, an indicator of KIDNEY DISEASES. | 0 | 4.55 | 1 | 1 |
Constipation Infrequent or difficult evacuation of FECES. These symptoms are associated with a variety of causes, including low DIETARY FIBER intake, emotional or nervous disturbances, systemic and structural disorders, drug-induced aggravation, and infections. | 0 | 4.55 | 1 | 1 |
Diarrhea An increased liquidity or decreased consistency of FECES, such as running stool. Fecal consistency is related to the ratio of water-holding capacity of insoluble solids to total water, rather than the amount of water present. Diarrhea is not hyperdefecation or increased fecal weight. | 0 | 4.55 | 1 | 1 |
Dizziness An imprecise term which may refer to a sense of spatial disorientation, motion of the environment, or lightheadedness. | 0 | 4.55 | 1 | 1 |
Syncope A transient loss of consciousness and postural tone caused by diminished blood flow to the brain (i.e., BRAIN ISCHEMIA). Presyncope refers to the sensation of lightheadedness and loss of strength that precedes a syncopal event or accompanies an incomplete syncope. (From Adams et al., Principles of Neurology, 6th ed, pp367-9) | 0 | 4.55 | 1 | 1 |
Proteinuria The presence of proteins in the urine, an indicator of KIDNEY DISEASES. | 0 | 2.17 | 1 | 0 |